BlackRock Inc. - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 78 filers reported holding DICE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$134,515,962
+55.9%
2,895,307
-3.9%
0.00%
+33.3%
Q1 2023$86,306,435
-9.4%
3,012,441
-1.3%
0.00%0.0%
Q4 2022$95,225,582
+146.3%
3,052,102
+60.1%
0.00%
+200.0%
Q3 2022$38,667,000
+45.0%
1,906,691
+10.9%
0.00%0.0%
Q2 2022$26,675,000
+62.0%
1,718,712
+99.7%
0.00%
Q1 2022$16,462,000
-24.0%
860,540
+0.6%
0.00%
-100.0%
Q4 2021$21,648,000855,2950.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders